Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-5684
Ozsahin, H; Cavazzana-Calvo, M; Notarangelo, L D; Schulz, A; Thrasher, A J; Mazzolari, E; Slatter, M A; Le Deist, F; Blanche, S; Veys, P; Fasth, A; Bredius, R; Sedlacek, P; Wulffraat, N; Ortega, J; Heilmann, C; O'Meara, A; Wachowiak, J; Kalwak, K; Matthes-Martin, S; Gungor, T; Ikinciogullari, A; Landais, P; Cant, A J; Friedrich, W; Fischer, A (2008). Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood, 111(1):439-445.
Wiskott-Aldrich syndrome (WAS) is a rare X-linked immunodeficiency with microthrombocytopenia, eczema, recurrent infections, autoimmune disorders, and malignancies that are life-threatening in the majority of patients. In this long-term, retrospective, multicenter study, we analyzed events that occurred in 96 WAS patients who received transplants between 1979 and 2001 who survived at least 2 years following hematopoietic stem-cell transplantation (HSCT). Events included chronic graft-versus-host disease (cGVHD), autoimmunity, infections, and sequelae of before or after HSCT complications. Three patients (3%) died 2.1 to 21 years following HSCT. Overall 7-year event-free survival rate was 75%. It was lower in recipients of mismatched related donors, also in relation with an older age at HSCT and disease severity. The most striking finding was the observation of cGVHD-independent autoimmunity in 20% of patients strongly associated with a mixed/split chimerism status (P < .001), suggesting that residual-host lymphocytes can mediate autoimmune disease despite the coexistence of donor lymphocytes. Infectious complications (6%) related to splenectomy were also significant and may warrant a more restrictive approach to performing splenectomy in WAS patients. Overall, this study provides the basis for a prospective, standardized, and more in-depth detailed analysis of chimerism and events in long-term follow-up of WAS patients who receive transplants to design better-adapted therapeutic strategies.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic|
|DDC:||610 Medicine & health|
|Deposited On:||06 Feb 2009 09:25|
|Last Modified:||27 Nov 2013 22:39|
|Publisher:||American Society of Hematology|
|Additional Information:||This research was originally published in Blood 2008, 111(1), 439-445. Copyright by the American Society of Hematology.|
|Citations:||Web of Science®. Times Cited: 65|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page